Director Shareholding
December 03 2001 - 12:07PM
UK Regulatory
RNS Number:1054O
Cambridge Antibody Tech Group PLC
3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Paul Nicholson
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of Directors Fees in lieu of cash
consideration.
7) Number of shares/amount of
stock acquired
307
8) Percentage of issued class
0.001%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
4,741
16) Total percentage holding of issued class following this notification
0.013%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Uwe Bicker
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of Directors Fees in lieu of cash
consideration.
7) Number of shares/amount of
stock acquired
307
8) Percentage of issued class
0.001%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
2,458
16) Total percentage holding of issued class following this notification
0.007%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Aaron Klug
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of Directors Fees in lieu of cash
consideration.
7) Number of shares/amount of
stock acquired
307
8) Percentage of issued class
0.001%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
28,527
16) Total percentage holding of issued class following this notification
0.080%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
James Foght
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of Directors Fees in lieu of cash
consideration.
7) Number of shares/amount of
stock acquired
307
8) Percentage of issued class
0.001%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
3,118
16) Total percentage holding of issued class following this notification
0.009%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
John Stocker
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of Directors Fees in lieu of cash
consideration.
7) Number of shares/amount of
stock acquired
307
8) Percentage of issued class
0.001%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
78,599
16) Total percentage holding of issued class following this notification
0.222%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Peter Garland
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Regular annual payment of part of Directors Fees in lieu of cash
consideration.
7) Number of shares/amount of
stock acquired
659
8) Percentage of issued class
0.020%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
41,825
16) Total percentage holding of issued class following this notification
0.0118%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
Kevin Johnson
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above and Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
The issue and allotment of 117 shares pursuant to the Cambridge Antibody
Technology Inland Revenue approved All Employee Share Ownership Plan.
7) Number of shares/amount of
stock acquired
117
8) Percentage of issued class
0.0003%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
63,834
16) Total percentage holding of issued class following this notification
0.180%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Glover
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above and Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
The issue and allotment of 117 shares pursuant to the Cambridge Antibody
Technology Inland Revenue approved All Employee Share Ownership Plan.
7) Number of shares/amount of
stock acquired
117
8) Percentage of issued class
0.0003%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
10,534
16) Total percentage holding of issued class following this notification
0.030%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
John Aston
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above and Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
The issue and allotment of 146 shares pursuant to the Cambridge Antibody
Technology Inland Revenue approved All Employee Share Ownership Plan.
7) Number of shares/amount of
stock acquired
146
8) Percentage of issued class
0.0004%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
12,725
16) Total percentage holding of issued class following this notification
0.036%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) Name of company
Cambridge Antibody Technology
2) Name of director
David Chiswell
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 Above and Computershare Trustees Limited
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
The issue and allotment of 117 shares pursuant to the Cambridge Antibody
Technology Inland Revenue approved All Employee Share Ownership Plan.
7) Number of shares/amount of
stock acquired
117
8) Percentage of issued class
0.0003%
9) Number of shares/amount
of stock disposed
Nil
10) Percentage of issued class
Nil
11) Class of security
10p Ordinary shares
12) Price per share
#17.07
13) Date of transaction
30 November 2001
14) Date company informed
30 November 2001
15) Total holding following this notification
476,334
16) Total percentage holding of issued class following this notification
1.343%
If a director has been granted options by the company please complete the
following boxes
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
Diane Mellett 01763 263233
25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary
Date of Notification 3 December 2001
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
